[go: up one dir, main page]

WO2016086022A3 - Composés imidazolyle hétéroaromatiques et méthodes de traitement du cancer - Google Patents

Composés imidazolyle hétéroaromatiques et méthodes de traitement du cancer Download PDF

Info

Publication number
WO2016086022A3
WO2016086022A3 PCT/US2015/062486 US2015062486W WO2016086022A3 WO 2016086022 A3 WO2016086022 A3 WO 2016086022A3 US 2015062486 W US2015062486 W US 2015062486W WO 2016086022 A3 WO2016086022 A3 WO 2016086022A3
Authority
WO
WIPO (PCT)
Prior art keywords
heteroaromatic
methods
treating cancer
compounds
imidazolyl compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2015/062486
Other languages
English (en)
Other versions
WO2016086022A2 (fr
Inventor
Kandalam V. RAMANUJACHARY
Subash C. JONNALAGADDA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pelthos Therapeutics Inc
Original Assignee
Channel Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Channel Therapeutics Inc filed Critical Channel Therapeutics Inc
Publication of WO2016086022A2 publication Critical patent/WO2016086022A2/fr
Publication of WO2016086022A3 publication Critical patent/WO2016086022A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La présente invention concerne des composés imidazolyle hétéroaromatiques, des compositions comprenant de tels composés, et des procédés associés de fabrication et d'utilisation des composés, par exemple, ces composés sont utiles pour le traitement de maladies telles que le cancer.
PCT/US2015/062486 2014-11-26 2015-11-24 Composés imidazolyle hétéroaromatiques et méthodes de traitement du cancer Ceased WO2016086022A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462085148P 2014-11-26 2014-11-26
US62/085,148 2014-11-26

Publications (2)

Publication Number Publication Date
WO2016086022A2 WO2016086022A2 (fr) 2016-06-02
WO2016086022A3 true WO2016086022A3 (fr) 2016-10-13

Family

ID=56075127

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2015/062486 Ceased WO2016086022A2 (fr) 2014-11-26 2015-11-24 Composés imidazolyle hétéroaromatiques et méthodes de traitement du cancer

Country Status (1)

Country Link
WO (1) WO2016086022A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106632331A (zh) * 2016-12-19 2017-05-10 盐城师范学院 一种检测糖尿病酮酸中毒因子的探针及其合成和使用方法
CN115266983B (zh) * 2022-07-29 2023-11-17 最高人民检察院检察技术信息研究中心 一种利用气相色谱质谱法对消毒产品抗、抑菌剂中抗真菌药物进行测定的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070123553A1 (en) * 2003-11-14 2007-05-31 Lorus Therapeutics Inc. Aryl imidazoles and their use as anti-cancer agents
CN101735217A (zh) * 2009-12-15 2010-06-16 广东药学院 咪唑[4,5-f][1,10]菲咯啉及其衍生物在制备抗肿瘤药物中的应用
US20110152337A1 (en) * 2002-08-19 2011-06-23 Lorus Therapeutics Inc. 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110152337A1 (en) * 2002-08-19 2011-06-23 Lorus Therapeutics Inc. 2,4,5-trisubstituted imidazoles and their use as anti-microbial agents
US20070123553A1 (en) * 2003-11-14 2007-05-31 Lorus Therapeutics Inc. Aryl imidazoles and their use as anti-cancer agents
CN101735217A (zh) * 2009-12-15 2010-06-16 广东药学院 咪唑[4,5-f][1,10]菲咯啉及其衍生物在制备抗肿瘤药物中的应用

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SERGEEVA, N. N. ET AL.: "Synthesis and evaluation of the europium III and zinc II complexes as luminescent bioprobes in high content cell -imaging analysis", JOURNAL OF INORGANIC BIOCHEMISTRY, vol. 105, no. 12, 2011, pages 1589 - 1595, XP028336561 *
SHI, S. ET AL.: "Targeting Human Telomeric G-Quadruplex DNA and Inhibition of Telomerase Activity With [(dmb)2Ru(obip)Ru(dmb)2]4+", PLOS ONE, vol. 8, no. 12, 2013, pages 1 - 15, XP055320038 *

Also Published As

Publication number Publication date
WO2016086022A2 (fr) 2016-06-02

Similar Documents

Publication Publication Date Title
EP3481402A4 (fr) Composés, compositions et méthodes de traitement de maladie
EP3448874A4 (fr) Compositions pour le traitement de maladies
EP3448987A4 (fr) Compositions pour le traitement de maladies
EP3675859A4 (fr) Composés, compositions et méthodes pour le traitement d'une maladie
EP3484504A4 (fr) Composés, compositions et méthodes de traitement de maladie
ZA201905902B (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
WO2016130920A3 (fr) Inhibiteurs de lrrk2 et leurs méthodes de production et d'utilisation
WO2017214170A3 (fr) Anticorps baff-r et utilisations de ceux-ci
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
WO2015179559A3 (fr) Composés de pyrazole, procédés de production et utilisation
EP3256438A4 (fr) Composés, compositions, et procédés de traitement de maladies inflammatoires, dégénératives, et neurodégénératives
WO2015120062A8 (fr) Composés et compositions thérapeutiques
EP3490561A4 (fr) Combinaisons pour le traitement du cancer
EA033460B1 (ru) Замещенные [1,2,4]триазольные соединения в качестве фунгицидов
EP3522873A4 (fr) Compositions et méthodes pour le traitement de la xérostomie
TWI799397B (zh) 用於治療高血壓之組合物
EP3503887A4 (fr) Combinaisons pour le traitement du cancer
WO2016094374A8 (fr) Compositions et méthodes de traitement de l'ataxie de friedreich
EP3288636A4 (fr) Compositions pour le traitement de l'epistaxis
HK1254231A1 (zh) 米托-和厚朴酚化合物及其合成方法和用途
EP3548007A4 (fr) Méthodes de traitement du cancer
EP3169405A4 (fr) Méthodes, composés et compositions pour le traitement de maladies musculo-squelettiques
EP3532055A4 (fr) Compositions et procédés pour la production de composés
HK1249756A1 (zh) 用於治疗疾病的稠合双环化合物
WO2016086022A3 (fr) Composés imidazolyle hétéroaromatiques et méthodes de traitement du cancer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15862985

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15862985

Country of ref document: EP

Kind code of ref document: A2